Fig. 1From: Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)The overall picture on how the new era of CGRP pathway interacting molecules is given below. These drugs are designer molecules that have been constructed as anti-migraine [1]Back to article page